BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34080844)

  • 1. Structural Characterization of Endogenous Tuberous Sclerosis Protein Complex Revealed Potential Polymeric Assembly.
    Dai DL; Hasan SMN; Woollard G; Abbas YM; Bueler SA; Julien JP; Rubinstein JL; Mazhab-Jafari MT
    Biochemistry; 2021 Jun; 60(23):1808-1821. PubMed ID: 34080844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Architecture of the Tuberous Sclerosis Protein Complex.
    Ramlaul K; Fu W; Li H; de Martin Garrido N; He L; Trivedi M; Cui W; Aylett CHS; Wu G
    J Mol Biol; 2021 Jan; 433(2):166743. PubMed ID: 33307091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis.
    Neuman NA; Henske EP
    EMBO Mol Med; 2011 Apr; 3(4):189-200. PubMed ID: 21412983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberous sclerosis complex: genetics to pathogenesis.
    Narayanan V
    Pediatr Neurol; 2003 Nov; 29(5):404-9. PubMed ID: 14684235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberous sclerosis: from tubers to mTOR.
    Kwiatkowski DJ
    Ann Hum Genet; 2003 Jan; 67(Pt 1):87-96. PubMed ID: 12556239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine controls insulin/mammalian target of rapamycin complex 1 activity by modulating tuberous sclerosis complex 2 stability.
    Gen S; Matsumoto Y; Suzuki T; Inoue J; Yamamoto Y
    Biochem Biophys Res Commun; 2021 Feb; 541():84-89. PubMed ID: 33482580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant beta-catenin signaling in tuberous sclerosis.
    Mak BC; Kenerson HL; Aicher LD; Barnes EA; Yeung RS
    Am J Pathol; 2005 Jul; 167(1):107-16. PubMed ID: 15972957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genomic landscape of tuberous sclerosis complex.
    Martin KR; Zhou W; Bowman MJ; Shih J; Au KS; Dittenhafer-Reed KE; Sisson KA; Koeman J; Weisenberger DJ; Cottingham SL; DeRoos ST; Devinsky O; Winn ME; Cherniack AD; Shen H; Northrup H; Krueger DA; MacKeigan JP
    Nat Commun; 2017 Jun; 8():15816. PubMed ID: 28643795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of Normal Cerebral Oxygen Consumption with Rapamycin Treatment in a Rat Model of Autism-Tuberous Sclerosis.
    Chi OZ; Wu CC; Liu X; Rah KH; Jacinto E; Weiss HR
    Neuromolecular Med; 2015 Sep; 17(3):305-13. PubMed ID: 26048361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis.
    Xiao GH; Shoarinejad F; Jin F; Golemis EA; Yeung RS
    J Biol Chem; 1997 Mar; 272(10):6097-100. PubMed ID: 9045618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
    Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
    IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis.
    Zech R; Kiontke S; Mueller U; Oeckinghaus A; Kümmel D
    J Biol Chem; 2016 Sep; 291(38):20008-20. PubMed ID: 27493206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.
    Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M
    J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of regions critical for the integrity of the TSC1-TSC2-TBC1D7 complex.
    Santiago Lima AJ; Hoogeveen-Westerveld M; Nakashima A; Maat-Kievit A; van den Ouweland A; Halley D; Kikkawa U; Nellist M
    PLoS One; 2014; 9(4):e93940. PubMed ID: 24714658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.
    Hino O; Kobayashi T
    Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
    Aicher LD; Campbell JS; Yeung RS
    J Biol Chem; 2001 Jun; 276(24):21017-21. PubMed ID: 11290735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1.
    Di Nardo A; Wertz MH; Kwiatkowski E; Tsai PT; Leech JD; Greene-Colozzi E; Goto J; Dilsiz P; Talos DM; Clish CB; Kwiatkowski DJ; Sahin M
    Hum Mol Genet; 2014 Jul; 23(14):3865-74. PubMed ID: 24599401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberous sclerosis complex: from Drosophila to human disease.
    Pan D; Dong J; Zhang Y; Gao X
    Trends Cell Biol; 2004 Feb; 14(2):78-85. PubMed ID: 15102439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TACCing on new functions for the TSC2 tumor suppressor.
    Golemis EA
    Cell Cycle; 2010 Apr; 9(7):1232-3. PubMed ID: 20404523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.